Silymarin for rheumatoid arthritis patients on methotrexate
Part of Bones, joints & muscles, Immune system & allergy, Skin clinical trials.
This trial tests if adding silymarin (a herbal supplement) to standard methotrexate treatment can help people with active rheumatoid arthritis. It aims to see if it reduces joint inflammation and improves symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have active rheumatoid arthritis, with a DAS-28 score above 2.6 (not in remission).
- You are between 18 and 60 years old.
- You are currently taking methotrexate and other conventional treatments.
- You do not have liver or kidney disease, such as chronic liver disease, cirrhosis, or alcoholic hepatitis.
- You are not using other antioxidant supplements besides silymarin.
- You are not pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether adding empagliflozin to methotrexate helps control active rheumatoid arthritis and protects joints. It may offer a new treatment option for people whose disease is still active despite methotrexate.
This study tests whether adding roflumilast, a new medication, to your current rheumatoid arthritis treatment can help reduce joint inflammation and improve your symptoms. You would take it alongside methotrexate, a common RA medication you may already be using.
This trial compares two additional medicines (diosmin or rebamipide) taken with standard arthritis treatment to see if they help reduce joint pain and swelling better than standard treatment alone.
This study tests a methotrexate injection (given under the skin) for people with moderate to severe rheumatoid arthritis who haven't taken methotrexate before. Researchers want to see how the medicine builds up in your body and if it helps control your symptoms.
This study looks at how well methotrexate injections work in people with rheumatoid arthritis. It is designed for patients who are starting or changing to this type of methotrexate treatment.
This trial tests whether a traditional Chinese herbal medicine, combined with your current rheumatoid arthritis medications, can reduce joint pain and swelling better than your current treatment alone. The study involves 6–12 months of treatment and regular check-ins with the research team.
Hear when a new Rheumatoid Arthritis (RA) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.